0 results

Patient Corner

Last reference updates

  • 19 Apr 2016 - Drug Updates

Drug safety alert: Risks of PML, basal-cell carcinoma, and opportunistic infections associated with Fingolimod (Gilenya▼)

Fingolimod can increase the risk of progressive multifocal leukoencephalopathy and opportunistic infections owing to its immunomodulatory effects.

Read more